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Dendritic cells (DCs) play critical roles in immune responses
and can be distinguished in two major subsets, myeloid and
plasmacytoid DCs. Although the presence of DC in all
peripheral organs, including the kidney, has been well
documented, no accurate estimates of DC subsets in human
kidneys have been reported. This study shows a detailed
analysis of DC subsets in cryosections of human renal tissue.
The cortex of normal kidneys contains at least two different
HLA-DRþ myeloid DC subtypes characterized by
BDCA-1þDC-SIGNþ and BDCA-1þDC-SIGN. The staining for
DC-SIGN completely overlapped with CD68 in the renal
interstitium. Unexpectedly, BDCA-2þDC-SIGN plasmacytoid
DCs are also abundantly present. Both subsets are located in
the tubulo–interstitium often with a high frequency around,
but rarely observed within glomeruli. Quantification of
BDCA-1þ , DC-SIGNþ , and BDCA-2þ cells in normal human
renal tissue (pretransplant biopsy living donors; n¼ 21)
revealed that BDCA-1 is about four times as frequently
present as BDCA-2. A preliminary cross-sectional analysis of
DC in diseased kidneys, including rejection and
immunoglobulin A nephropathy, revealed that the number
of DC as well as their anatomical distribution might change
under pathophysiological conditions. In conclusion, we show
that human kidneys contain a dense network of myeloid and
plasmacytoid DCs and provide the tools for phenotyping and
enumeration of these cells to better understand
interindividual differences in immune responses.
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Dendritic cells (DCs) are uniquely well equipped, bone
marrow-derived antigen-presenting cells that play critical
roles in the initiation and regulation of immune responses.1–3
In peripheral non-lymphoid tissues, DCs are found as
immature interstitial antigen-presenting cells. A fundamental
aspect of DC function is their capacity to migrate. Under
steady-state conditions, migration of DCs from blood to
tissues and from tissues to lymph nodes is present but
relatively low,4 which may play an important role in the
maintenance of self-tolerance.5 Danger signals enhance the
rate of DC migration and also induce maturation of DCs,
which decreases their capacity to capture antigen but enables
the cells to translocate the immunogenic peptide–major
histocompatibility complex (MHC) complexes in concert
with costimulatory molecules to their cell surface to stimulate
antigen-specific T cells.6–8
In humans, DCs comprise at least three distinct subsets:
Langerhans cells (LCs) and interstitial DCs, both belonging
to the CD11cþ myeloid lineage, and CD11c plasmacytoid
DCs, which are thought to originate from a lymphoid
precursor.9 LCs are localized in the basal and suprabasal
layers of the epidermis in the skin and other mucosal areas,
whereas interstitial DCs are present in the dermis of the skin
and in most other organs. LCs specifically express CD1a and
the C-type lectin langerin,10 whereas interstitial DCs lack
these markers but do express blood DCs antigen (BDCA)-1/
CD1c11 and/or the C-type lectin DC-SIGN.12 Plasmacytoid
DCs were originally defined as CD11cCD123þHLA-DRþ
cells found in the T-cell zones of lymphoid organs that
possess the unique ability to secrete large amounts of
interferon-a/b on viral stimulation.13 Also, these DCs
specifically express a C-type lectin, that is BDCA-2.
Renal DCs were first described in rats as Iaþ (MHC class
IIþ ) cells present in the interstitium in immunohistochemi-
cal studies by Hart and Fabre in 198114,15 and as a small
percentage of glomerular cells.16 In vivo depletion and
reconstitution studies have demonstrated an important role
within kidney allografts in providing the primary eliciting
stimulus of rejection.17,18 There is accumulating evidence
that the qualitative and quantitative nature of passenger
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leukocytes in an allograft is important in determining graft
outcome.19 Despite the importance ascribed to donor-
derived DCs in determining graft outcome, no thorough
investigation of total DCs or DC subsets in human kidneys
have been reported. In recent years, more detailed informa-
tion has been obtained on the presence and function of DC in
mouse kidneys.20,21 Importantly, using a CX3CR1-green
fluorescent protein knockin model, it was shown that in
the kidney interstitial DCs form a dense network.22 Studies
on human renal DCs were hampered by the lack of DC-
specific markers. Renal DCs have been studied in animal
models using MHC class II antibodies.23,24 However, it was
clearly shown that HLA-DR is not only expressed by antigen-
presenting cells, but class II expression is also constitutively
expressed on peritubular and glomerular capillary endothe-
lium.25–28 Furthermore, HLA-DR does not discriminate
between the different DC subsets.
In this study, a detailed analysis of DC subsets in the
human kidney is performed. We demonstrate that normal
human kidneys contain at least two different DC subsets, that
is, BDCA-1þDC-SIGNþ /HLA-DRþ myeloid DCs (also
called DC129) and BDCA-2þHLA-DRþ lymphoid DCs (also
called DC229). The number of DCs in pretransplant biopsies
of living (un)related donors, the best approach of normal
human renal tissue, was determined by detection of DC-
SIGNþ , BDCA-1þ , or BDCA-2þ cells.
RESULTS
Human kidneys contain multiple DC-SIGNþ DCs
Owing to lack of specific DC markers, it has been difficult to
detect DCs in human kidneys for a long time. One of the first
identified human DC-specific molecules is the lectin DC-
SIGN, which is thought to be specifically expressed on
myeloid DCs.12 According to previous reports,12,30 immu-
nohistochemical staining of human tonsils, using either a
monoclonal or a polyclonal antibody directed to DC-SIGN,
demonstrated the presence of DC-SIGN-expressing cells in
the T-cell areas (Figure 1a). The same techniques for
immunohistochemical analysis of renal tissue revealed multi-
ple DC-SIGNþ cells in the tubulo–interstitium of the renal
cortex, often with a high frequency around, but rarely (1/50
glomeruli) observed within glomeruli (Figure 2a and b).
Some of the DC-SIGNþ cells clearly showed the dendritic
processes that protruded into the peritubular spaces
(Figure 2b).
As reported previously,28 immunohistochemical staining
for HLA-DR showed HLA-DR expression on endothelial cells
of the glomerular and peritubular capillaries, but not on the
endothelium of larger vessels, and possibly also on interstitial
antigen-presenting cells (Figure 2d). Double stainings for
HLA-DR and DC-SIGN revealed that many DC-SIGNþ cells
showed HLA-DR expression (Figure 2c). However, some DC-
SIGNþ cells demonstrated a relatively low HLA-DR expres-
sion. Both histochemical and fluorescent stainings using
mouse immunoglobulin (Ig)G were negative (Figure 2e).
Human kidneys contain myeloid DC subsets
To identify further the DC subset(s) present in the human
kidney, cortical tissue was immunostained with antibodies
directed against CD68 and BDCA-1 (CD1c). CD68 has been
originally defined as macrophage marker. In human tonsils,
intense CD68 expression is found not only in germinal
centers, T-cell areas also contain CD68þ cells, in line with
previous reports31 (Figure 1b). However, CD68 can also be
expressed by interstitial DCs.32 In circulation, BDCA-1 is,
apart from a subset of B cells, exclusively expressed on the
myeloid DC-precursor cells.11 In human tonsils, BDCA-1-
expressing cells are mainly located in the T-cell area
representing the myeloid interdigitating DCs, a few BDCA-
1þ cells were also detected in the B-cell areas (Figure 1c).
Both immunohistochemical and fluorescent stainings for
CD68 in human kidneys revealed that interstitial cells clearly
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Figure 1 | Expression of DC-related molecules in human tonsil. Cryosections of human tonsils were stained immunohistochemically for
(a) DC-SIGN, (b) CD68, (c) BDCA-1, (d) BDCA-2, and (e) DC-LAMP as described in Materials and Methods. (f) Mouse IgG was used as a negative
control. Original magnifications were  100.
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expressed CD68, and glomeruli also demonstrated a weak
staining for the molecules (Figure 3a). Combined detection
of DC-SIGNþ cells demonstrated that CD68 colocalizes with
DC-SIGN in the renal interstitium and only a few single DC-
SIGNþ or CD68þ cells could be observed (Figure 3a–c).
Staining for BDCA-1 demonstrated that multiple positive
cells are present in the tubulo–interstitial area with a high
frequency around glomeruli (Figures 3d and 4a). Again, the
presence of BDCA-1þ cells within glomeruli was rarely
observed. Detection of HLA-DR in consecutive sections
suggested that all BDCA-1þ cells do also express HLA-DR
(data not shown). Double staining with DC-SIGN revealed
that all DC-SIGNþ cells coexpress BDCA-1, whereas many
BDCA-1þ cells did not stain for DC-SIGN (Figure 3d–f).
These stainings show that at least two myeloid DC subsets, or
distinct differentiation stages, are present in the renal cortex,
that is, BDCA-1þDC-SIGNþ cells that also seem to express
CD68 and BDCA-1þDC-SIGN DCs, which are negative for
CD68. It is unlikely that mature DCs are present in these
biopsies, as presence of DC-LAMPþ cells, a marker of
mature DCs clearly present in T-cell areas of human tonsil
(Figure 1e),26 could not be detected (Figure 4c).
Human kidneys contain plasmacytoid DCs
To assess whether human kidneys also contain plasmacytoid
DCs, the expression of BDCA-2 was analyzed. BDCA-2 is a
lectin specifically found on plasmacytoid DCs.11,33 Although






Figure 2 | Human kidneys contain DC-SIGNþHLA-DRþ DCs.
Cryosections of normal human kidneys were stained
immunohistochemically for (a and b) DC-SIGN and (d) HLA-DR as
described in Materials and Methods. Black arrows indicate examples
of DC-SIGNþ cells around glomeruli. (e) Mouse IgG was used as a
negative control. (c) Cryosections of normal human kidneys were
immunofluorescently stained for HLA-DR (green) and DC-SIGN
(polyclonal antibody; red) as described in Materials and Methods.
DC-SIGNþ cells with an undetectable HLA-DR expression are marked
with an asterisk. White arrows indicate DC-SIGNþHLA-DRþ cells.
(a, d, and e) Original magnifications were either  100 or (b and d)




Figure 3 | Human kidneys contain myeloid and plasmacytoid DCs. Cryosections of normal human kidneys were stained for (a and c) CD68,
(d and f) BDCA-1, or (g and i; all in green) BDCA-2 in combination with (polyclonal antibody; b, c, e, f, h, and i; red) DC-SIGN as described
in Materials and Methods. Original magnifications were  100. Pictures are representative for four different donors.
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human tonsils, their frequency was lower than for myeloid
DC-SIGNþ or BDCA-1þ cells (Figure 1d). We found that
the tubulo–interstitium of human kidneys also contained
BDCA-2þ cells (Figures 3g and 4b). Although the frequency
of BDCA-2þ cells within the interstitium was clearly lower,
the localization of these BDCA-2þ cells was very comparable
with the BDCA-1þ and DC-SIGNþ cells. Immunohisto-
chemical stainings of consecutive biopsies showed that
BDCA-2þ cells coexpress HLA-DR (data not shown). As
expected, minimal colocalization was observed between
the myeloid DC-marker DC-SIGN and the plasmacytoid
DC-marker BDCA-2 as determined by immunofluorescent
double stainings (Figure 3g–i).
On consecutive sections, it was demonstrated that most
cells stained either for BDCA-1 or BDCA-2. However, in
several cases it seemed that BDCA-1 and BDCA-2 were
present on the same cells. It has been shown previously that
myeloid DC markers can be expressed on BDCA-2þ DCs.32
However, as DCs display a dense network around the tubuli
and glomeruli it is difficult to identify the same cell in
consecutive sections. Only confocal microscopy of fluores-
cent double stainings will be conclusive in determining
possible colocalization of BDCA-1 and BDCA-2, but this is
technically not feasible with the current reagents.
DC enumeration in pretransplant biopsies of living
(un)related donors
Pretransplant biopsies of living donors are the best possible
approach to investigate the distribution of DC subsets in
normal human renal tissue. To quantify better this cellular
distribution and to investigate interindividual variation and
possible relation with clinical parameters, we selected
pretransplant biopsies of 21 living (un)related kidney donors
between 29 and 64 years old. With a median of 6.8 104
BDCA-1þ pixels/area (range 4.0 104–13.1 104), myeloid
DC seemed to be about four times as frequently present
compared with BDCA-2þ cells (median: 1.5 104 range
0.3 104–3.0 104) (Figure 5). DC-SIGNþ cells were found
with a median of 4.8 104 pixels/area (range
10.2 104–8.0 104). No correlation was observed between
BDCA-1 and DC-SIGN or BDCA-2 and DC-SIGN, but the
area of BDCA-2þ cells present in cortical renal tissue of the
donors significantly correlated with the BDCA-1þ area
(P¼ 0.004; r¼ 0.65). Furthermore, the renal expression of
BDCA-1þ , DC-SIGNþ , or BDCA-2þ cells did not sig-
nificantly correlate with age, gender, or the induction of acute
rejection.
DC enumeration in biopsies of diseased kidneys
To investigate whether these different DC subsets are also
present in diseased kidneys and to investigate their
anatomical distribution, DC-SIGNþ , BDCA-1þ , and
BDCA-2þ cells were visualized and quantified in cryo-
sections of renal biopsies of patients suffering from IgA
nephropathy (IgAN) and renal allograft rejection. Quanti-
fication of the different DC-specific markers revealed a
significant increase in DC-SIGNþ cells in rejection compared
with healthy controls (Figures 6 and 7a). The level of DC-
SIGN expression did not significantly differ between
pretransplant biopsies and biopsies with IgAN (Figure 6).
However, like in the biopsies with rejection, biopsies derived
from patients with IgAN demonstrated more intraglomerular
DC-SIGN expression compared with pretransplant biopsies
(71/12 versus 1/50) (Figure 7d). As was found for
pretransplant biopsies, also in diseased kidneys DC-SIGNþ
cells were present in the interstitium with often a high
frequency around glomeruli, which is in line with the DC
distribution in experimental glomerulonephritis in mice21
and in interstitial infiltrates such as present in biopsies with
rejection.
a b c
Figure 4 | Expression of BDCA-1 and BDCA-2 in the human kidney. Cryosections of normal human kidneys were stained
immunohistochemically (a) for BDCA-1, (b) BDCA-2, and (c) DC-LAMP as described in Materials and Methods. Original magnifications were





















Figure 5 | DC enumeration in pretransplant biopsies. Cryosections
of pretransplant biopsies (n¼ 21) were immunohistochemically
stained for DC-SIGN (AZN-D1), BDCA-1, or BDCA-2 and quantified as
described in Materials and Methods. Data represent the positive areas
and are presented in a box-and-whisker plot, which demonstrates the
median, the quartiles, and the smallest and greatest values in the
distribution.
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The overall level of expression of BDCA-1 (Figure 7b
and e) and BDCA-2 (Figure 7c and f) did not significantly
differ (Figure 6). Although this cross-sectional analysis of
diseased and healthy kidneys is performed on a very small
population, it nicely demonstrates that DC subset distribu-
tion could be differentially regulated and might be related to
immunopathogenesis and/or disease outcome.
DISCUSSION
Using a set of specific markers, we show that human kidneys
contain a dense network of at least three different DC subsets.
Although the presence of DC in peripheral organs is known
for a long time, relatively little is known of the presence or
frequency of DC subsets in the human kidney. These studies
have been hampered by the fact that antibodies against MHC
class II, which have been a useful tool in other species or
organs,23,24 stain positive with peritubular capillaries in
human kidneys.28 The HLA-DRþ DC populations in the
cortex of normal kidneys could be divided into two main
populations based on their phenotypic characteristics:
myeloid DCs expressing BDCA-1 in the presence or absence
of DC-SIGN constituted the majority, whereas BDCA-
2þCD123þ plasmacytoid DCs were less frequently present.
The DCs are located in the tubulo–interstitial area, with often
a high frequency around glomeruli and vessels. The
expression pattern of HLA-DR, which differed in intensity
among the DC-SIGNþ cells, may reflect different DC
activation stages present in the kidney.34 The presence of
mature DCs was unlikely as no DC-LAMPþ cells could be
detected in healthy renal tissue (Figure 4c).
Although CD68 has traditionally been defined as macro-
phage marker, a strong colocalization was observed between
DC-SIGN and CD68. In vitro studies have shown that
interstitial DCs can indeed express CD68,32 whereas in vitro
cultured macrophages are negative for DC-SIGN.32 In
addition, human lung DCs were found to express both
CD68 and DC-SIGN35 and also mouse renal DCs, identified
by CD11c expression, express the macrophage-like molecule
F4/80.21 However, this colocalization of CD68 and DC-SIGN
is not observed under all conditions. For instance, CD68
staining of tonsillar sections showed a very strong staining for
tingable body macrophages in germinal centers, whereas the
same sections only showed very limited DC-SIGN staining in
germinal centers. This suggests that at this interface of
macrophages and DC, different phenotypic subsets can be
identified and it will be a major challenge to link this to
functional characteristics.
We observed that the intensity of MHC class II expression
was heterogeneous and some DC-SIGNþ cells were shown to
be low in MHC expression (Figure 2c). This is in line with
murine data, where mouse CD11cþ renal DCs were also
heterogeneous in their MHC class II expression.21 In addition
to the similarities between mouse and human renal myeloid
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Figure 7 | Tissue distribution of DC subsets in diseased kidneys. (a–c) Cryosections of renal biopsies of patients suffering from renal allograft
rejection or (d–f) IgAN were stained for (a and d) DC-SIGN, (b and e) BDCA-1, and (c and f) BDCA-2 as described in Materials and
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Figure 6 | Quantification DC subsets in diseased kidneys.
Cryosections of renal biopsies of patients suffering from renal
allograft rejection (n¼ 6) or IgAN (n¼ 6) were stained for DC-SIGN
(AZN-D1), BDCA-1, and BDCA-2 as described in Materials and
Methods. Single dots represent the positive areas in each
section/biopsy. Horizontal lines represent the median expression.
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DCs regarding their coexpression of DC- and macrophage-
like molecules, the frequency and location of those myeloid
DCs in the renal interstitium are also very similar.21,22
Unfortunately, limitations in the amount of human tissue
available precludes isolation and functional characterization
of renal DC, as was performed with mouse renal DC.20–22
DC-SIGNþBDCA-1þ DC precursors present in human
peripheral blood36 are very likely the precursors of DC-
SIGNþBDCA-1þ interstitial DCs found in renal tissue. The
renal BDCA-1þDC-SIGN DC population might have lost
DC-SIGN after recruitment from the blood circulation, but
may represent a second myeloid DC subset. Also in human
lung, it has been found that BDCA-1þ DCs represent
different subsets, that is, CD1a DCs and CD1aþ LCs,37,38
but the expression of DC-SIGN on these cells has not been
documented. Whether renal BDCA-1þDC-SIGN DCs
might have features of typical LCs needs further research.
Quantitative analysis of kidney sections revealed that the
number of renal DCs varies between healthy donors. The
significant, but relatively weak, correlation between BDCA-1
and BDCA-2 in individuals suggests on the one hand that yet
unidentified factors determine the level of recruitment of
both myeloid and plasmacytoid DCs from circulation to the
kidney. In contrast, this also suggests that specific factors, like
DC-specific chemokines, determine a preferential recruit-
ment of a certain DC subset. Renal BDCA-1 expression was
about four times as frequently present compared with BDCA-
2. This positive pixel area may not completely equate with
absolute DC numbers, but it nicely illustrates that myeloid
BDCA-1þ DCs are more frequently present than BDCA-2þ
plasmacytoid DCs. These plasmacytoid DCs were originally
thought to be present only in blood and lymphoid tissues.
Under steady-state conditions, plasmacytoid DCs have been
demonstrated in human nasal mucosa,37 but there they were
much less frequently present compared with the frequency of
BDCA-2þ cells observed in the human kidney. Whether
these renal BDCA-2þ cells are able to produce type I
interferons in response to viral infection, as a hallmark of
plasmacytoid DC function,13 remains to be elucidated.
Also in human adult peripheral blood, precursors for
myeloid BDCA-1þ DCs (pDC1) are the quantitatively
dominant subtype.39,40 In children, it is known that pDC1
do not significantly change with age, whereas the number of
precursors for plasmacytoid DCs (pDC2) decreases with
age.41,42 Estimates of pDC1 and pDC2 in adult blood during
aging or myeloid DCs (DC1) and plasmacytoid DCs (DC2)
in peripheral tissues have not been reported. The present data
suggest that age does not play a major role in the number of
renal DCs in the adult kidney.
From animal studies, it has been suggested that the
survival of solid organ allografts is related to the density of
the donor DC network in the graft.19 In addition, several
studies on peripheral blood DC subsets now propose that the
precursor ratio of myeloid (pDC1) and plasmacytoid (pDC2)
DCs reflects the immune status of an individual with
respect to tolerance versus immunity,40,43,44 rather than the
absolute frequencies. In this small group of renal transplant
recipients, neither the absolute number of DCs nor the ratio
of myeloid versus plasmacytoid DCs in the donor kidney
(¼ pretransplant biopsy) was related to the incidence of
acute rejection.
A preliminary cross-sectional analysis of the tissue
distribution of DC subsets in diseased kidneys, including
rejection and IgAN, revealed that the number as well as their
anatomical distribution might change under pathophysiolo-
gical conditions. Until now the presence of DC subsets in the
healthy and damaged kidney and their contribution to
pathogenesis and disease outcome have not been identified,
which precludes intervention at an early stage. Identifying
which DC subsets, either donor or recipient-derived, are
associated with specific immune responses and renal graft
function should permit us to develop new tools to
manipulate the immune response to self- as well as
alloantigens. This study made a start with the determination
of renal DCs and demonstrates the presence of both myeloid
and plasmacytoid DCs in the human kidney. Interindividual
differences exist with respect to the number of intragraft DC
that may reflect the state of immunogenicity of the organ.
MATERIALS AND METHODS
Tissue specimens
Expression of DC-related molecules was determined in cortical
tissue of human kidneys not suitable for transplantation because of
anatomical reasons (n¼ 5) or of pretransplant biopsies. DC
enumeration was performed in pretransplant biopsies of a group
of patients that received kidneys of living (un)related donors (donor
age 29–64 years) with a complete HLA-DR mismatch between 1997
and 2003. For development and validation of the DC staining, we
used tonsillar sections. To investigate alterations in DC numbers
under inflammatory conditions, we also stained sections of renal
biopsies of patients suffering from IgAN (n¼ 6) or renal allograft
rejection (n¼ 6).
Immunohistochemical staining
Frozen 4 mm tissue sections were used to determine the expression of
DC-specific markers (Table 1). After the sections were fixed with
acetone, endogenous peroxidase activity was blocked with 0.1%
H2O2 and 0.1% NaN3 for 30 min at room temperature (RT). Then
the slides were washed and subsequently blocked with phosphate-
buffered saline (PBS), 1% bovine serum albumin and 5% heat-
inactivated normal human serum for 45 min at RT. Next, sections
were incubated with the primary antibody in PBS, 1% bovine serum
albumin and 1% serum albumin normal human serum in a humid
atmosphere overnight at RT. After washing with PBS, antibody
binding was detected with horseradish peroxidase (HRP)-labeled
goat anti-mouse Ig (DAKO, Glostrup, Denmark) or HRP-labeled
goat anti-rabbit Ig (Jackson Immunoresearch Laboratories, Cam-
bridgeshire, UK) in PBS, 1% bovine serum albumin and 1% normal
human serum (60 min RT) followed by washing with PBS,
incubation with Tyramide-fluorescein isothiocyanate in tyramide
buffer (NENTM Life Science Products, Boston, MA, USA; 30 min
RT), washing with PBS, incubation with HRP-conjugated rabbit
anti-fluorescein isothiocyanate (DAKO) for 60 min at RT, washing
with PBS and development with VECTORs NovaREDTM (Brunsch-
wig, Burlingame, CA, USA), or DAB (Sigma, St Louis, MO, USA).
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Sections were counterstained with hematoxylin (Merck, Darmstadt,
Germany) and mounted with imsol (Klinipath, Duiven, The
Netherlands). To test the specificity, the primary antibody was
replaced by mouse IgG.
Immunofluorescent staining
Frozen 4–7 mm tissue sections of human kidneys, technically not
suitable for clinical transplantation (Eurotransplant, Leiden, The
Netherlands) or pretransplant biopsies of renal allografts, were used
to determine the intragraft expression of DC-specific markers
(Table 1). Sections were treated as described above. To visualize
HLA-DR, the primary antibody was followed by goat anti-mouse
Oregon Green (Molecular Probes, Leiden, The Netherlands), rabbit
anti-DC-SIGN was detected by goat anti-rabbit HRP followed by
tyramide-TRITC (Perkin Elmer, Boston, MA), and BDCA-1 and
BDCA-2 were detected with either goat anti-mouse HRP followed
by tyramide-TRITC or an amplification system containing DIG-
conjugated sheep(Fab)-anti-mouse (Roche Diagnostics, Almere,
The Netherlands), mouse anti-DIG (3B1/7A1, kindly provided
by Professor AM Deelder, Department of Parasitology, Leiden
University Medical Centre, Leiden, The Netherlands), and goat anti-
mouse Oregon Green. Cross-reactivity of the different detection
systems towards primary antibodies in double stainings was checked
and excluded. Sections were mounted with DABCO glycerol
(Sigma).
Quantification and statistical analysis of DCs in renal cortex
The amount of DCs in renal cortex was determined by area
measurement. Representative pictures of each biopsy were taken
with an original magnification of  100. Positively stained area was
measured in four to six pictures using the digital image analysis
program ImageJ (website http://rsb.info.nih.gov/ij/). A macro was
designed in which the color signal is split into red, green, and blue.
The values of the blue channel were used for further analysis.
Positively stained area is expressed in pixels per area. For each
biopsy, means and/or medians of the areas positive for DC-SIGN,
BDCA-1, or BDCA-2 were calculated and related to each other and
to gender, age, and number of rejection treatments by determining
Kendall’s tau-b correlation coefficient. P-values less than 0.05 were
considered significant.
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